. 2022 Oct 31;30(4):611–621. doi: 10.5606/tgkdc.dergisi.2022.21672

Table 3. Statistical comparison of KRECs (106 PMBC) between the three primary indication groups.

KRECs (10⁶ PMBC)	Primary indications						p¹
	IPF		COPD		Others^b
	Mean±SD	Median	Mean±SD	Median	Mean±SD	Median
Preop	15x105±19x105	7x105	6x105±8x105	4x105	32x105±37x105	26x105	0.521
Postop 24^th h	4x105±4x105	2x105	98x105±187x105	5x105	49x105±71x105	21x105	0.931
Postop 7^th day	6x105±6x105	5x105	40x105±76x105	2x105	121x105±220x105	158x105	0.075
Preop-postop 24^th h p²	0.593		0.715		0.465
Preop-postop 7^th day p²	0.593		1.000		0.144
Postop 24^th h-postop 7^th day p²	0.285		0.144		0.068
KRECs: Kappa-deleting recombination excision circles; PMBC: Peripheral blood mononuclear cell; IPF: Idiopathic pulmonary fibrosis; COPD: Chronic obstructive pulmonary disease. SD: Standard deviation; Preop: Pre-operation; 1 Kruskal-Wallis test; 2 Wilcoxon sign-rank test; b Other primary indication; p>0.05; bronchiectasis, silicosis and cystic fibrosis.